ARCHIVES

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

NCI Starts “Exceptional Responders” Study

September 26, 2014

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992